Atara Biotherapeutics logo

Atara Biotherapeutics Share Price Today

(NASDAQ: ATRA)

Atara Biotherapeutics share price is $6.91 & ₹604.16 as on 1 Mar 2025, 2.30 'hrs' IST

$6.91

0.02

(0.29%)

Market is closed - opens 8 PM, 03 Mar 2025

View live Atara Biotherapeutics share price in Dollar and Rupees. Guide to invest in Atara Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Atara Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Atara Biotherapeutics share price movements

  • Today's Low: $6.58
    Today's High: $7.01

    Day's Volatility :6.13%

  • 52 Weeks Low: $5.40
    52 Weeks High: $20.81

    52 Weeks Volatility :74.05%

Atara Biotherapeutics (ATRA) Returns

PeriodAtara Biotherapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-47.41%
1.4%
0.0%
6 Months
1.47%
-5.1%
0.0%
1 Year
-63.18%
1.8%
0.0%
3 Years
-96.88%
12.9%
-13.0%

Atara Biotherapeutics (ATRA) Key Statistics

in dollars & INR

Previous Close
$6.89
Open
$6.82
Today's High
$7.01
Today's Low
$6.58
Market Capitalization
$39.7M
Today's Volume
$97.9K
52 Week High
$20.8125
52 Week Low
$5.4
Revenue TTM
$100.4M
EBITDA
$-114.2M
Earnings Per Share (EPS)
$-25.32
Profit Margin
-132.58%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2014.86%

How to invest in Atara Biotherapeutics Stock (ATRA) from India?

It is very easy for Indian residents to invest directly in Atara Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atara Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atara Biotherapeutics or ATRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atara Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atara Biotherapeutics shares which would translate to 0.127 fractional shares of Atara Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atara Biotherapeutics, in just a few clicks!

Returns in Atara Biotherapeutics (ATRA) for Indian investors in Rupees

The Atara Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atara Biotherapeutics investment value today

Current value as on today

₹42,324

Returns

₹57,676

(-57.68%)

Returns from Atara Biotherapeutics Stock

₹63,186 (-63.19%)

Dollar Returns

₹5,510 (+5.51%)

Indian investors sentiment towards Atara Biotherapeutics (ATRA)

-61%

Period: Jan 31, 2025 to Mar 2, 2025. Change in 30 Days versus previous period

Search interest for Atara Biotherapeutics Stock from India on INDmoney has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Atara Biotherapeutics

  • EcoR1 Capital, LLC

    9.24%

  • Redmile Group, LLC

    7.67%

  • Citadel Advisors Llc

    4.52%

  • Bank of America Corp

    3.56%

  • Vanguard Group Inc

    3.10%

  • Vestal Point Capital LP

    2.17%

Analyst Recommendation on Atara Biotherapeutics

Buy

    61%Buy

    30%Hold

    7%Sell

Based on 13 Wall street analysts offering stock ratings for Atara Biotherapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
4
4
4
Sell
1
1
1

Analyst Forecast on Atara Biotherapeutics Stock (ATRA)

What analysts predicted

Upside of 91.75%

Target:

$13.25

Current:

$6.91

Insights on Atara Biotherapeutics Stock (Ticker Symbol: ATRA)

  • Price Movement

    In the last 3 months, ATRA stock has moved down by -45.7%
  • Increasing Revenue

    Revenue is up for the last 6 quarters, 957.0K → 40.19M (in $), with an average increase of 44.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -19.04M → -21.90M (in $), with an average decrease of 15.0% per quarter
  • ATRA vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 64.7% return, outperforming this stock by 128.8%
  • ATRA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 46.8% return, outperforming this stock by 143.9%
  • Price to Sales

    ForATRA every $1 of sales, investors are willing to pay $0.4, whereas for Beone Medicines Ltd, the investors are paying $7.5 for every $1 of sales.

Atara Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Atara Biotherapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Atara Biotherapeutics (ATRA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atara Biotherapeutics Inc logo
-18.9%
1.47%
-63.18%
-96.88%
-97.9%
Regeneron Pharmaceuticals, Inc. logo
4.78%
-40.22%
-28.05%
12.63%
41.59%
Beone Medicines Ltd logo
21.68%
44.37%
61.92%
54.11%
72.15%
Vertex Pharmaceuticals Incorporated logo
2.0%
0.86%
13.15%
101.03%
95.58%
Alnylam Pharmaceuticals, Inc. logo
-10.13%
-2.77%
64.46%
50.05%
110.47%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atara Biotherapeutics Inc logo
NA
NA
0.0
-4.24
-20.15
-0.45
NA
-15.77
Regeneron Pharmaceuticals, Inc. logo
18.34
18.34
1.04
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.17
-0.19
-0.06
NA
31.36
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.32
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.53
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atara Biotherapeutics Inc logo
Buy
$39.7M
-97.9%
NA
-132.58%
Regeneron Pharmaceuticals, Inc. logo
Buy
$76.8B
41.59%
18.34
31.07%
Beone Medicines Ltd logo
NA
$29.3B
72.15%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$121.8B
95.58%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$30.7B
110.47%
NA
-12.37%

About Atara Biotherapeutics

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as nasopharyngeal carcinoma. Its CAR T immunotherapy pipeline products include ATA3219, currently in Phase 1 trials, as well as ATA3431, under preclinical trials for the treatment of B-cell malignancies and autoimmune diseases; and ATA188 that is in Phase 2 clinical trials to treat multiple sclerosis. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.
Organization
Atara Biotherapeutics
Employees
159
CEO
Dr. Anhco Nguyen Ph.D.
Industry
Health Technology

Management People of Atara Biotherapeutics

NameTitle
Dr. Anhco Nguyen Ph.D.
President, CEO & Director
Mr. Eric Hyllengren
Executive VP, COO & CFO
Alex Chapman
Vice President of Corporate Communications & Investor Relations
Ms. Jill Henrich
Executive VP & Chief Regulatory officer
Ms. Rajani Dinavahi M.D.
Senior VP & Chief Medical Officer

Important FAQs about investing in ATRA Stock from India :

What is Atara Biotherapeutics share price today?

Atara Biotherapeutics share price today stands at $6.91, Open: $6.82 ; Previous Close: $6.89 ; High: $7.01 ; Low: $6.58 ; 52 Week High: $20.81 ; 52 Week Low: $5.40.

The stock opens at $6.82, after a previous close of $6.89. The stock reached a daily high of $7.01 and a low of $6.58, with a 52-week high of $20.81 and a 52-week low of $5.40.

Can Indians buy Atara Biotherapeutics shares?

Yes, Indians can invest in the Atara Biotherapeutics (ATRA) from India.

With INDmoney, you can buy Atara Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Atara Biotherapeutics at zero transaction cost.

How can I buy Atara Biotherapeutics shares from India?

It is very easy to buy Atara Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atara Biotherapeutics (ATRA) be purchased?

Yes, you can buy fractional shares of Atara Biotherapeutics with INDmoney app.

What are the documents required to start investing in Atara Biotherapeutics stocks?

To start investing in Atara Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Atara Biotherapeutics Stock (ATRA)?

Today’s highest price of Atara Biotherapeutics (ATRA) is $7.01.

Today’s lowest price of Atara Biotherapeutics (ATRA) is $6.58.

What is today's market capitalisation of Atara Biotherapeutics?

Today's market capitalisation of Atara Biotherapeutics ATRA is 39.7M

What is the 52 Week High and Low Range of Atara Biotherapeutics Stock (ATRA)?

  • 52 Week High

    $20.81

  • 52 Week Low

    $5.40

What are the historical returns of Atara Biotherapeutics (ATRA)?

  • 1 Month Returns

    -18.9%

  • 3 Months Returns

    1.47%

  • 1 Year Returns

    -63.18%

  • 5 Years Returns

    -97.9%

Who is the Chief Executive Officer (CEO) of Atara Biotherapeutics ?

Dr. Anhco Nguyen Ph.D. is the current Chief Executive Officer (CEO) of Atara Biotherapeutics.